Department of Otorhinolaryngology-Head and Neck Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Center for Liquid Biopsy and Cohort Research, and Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Front Endocrinol (Lausanne). 2021 Dec 7;12:795281. doi: 10.3389/fendo.2021.795281. eCollection 2021.
In the past decade, the use of intraoperative neural monitoring (IONM) in thyroid and parathyroid surgery has been widely accepted by surgeons as a useful technology for improving laryngeal nerve identification and voice outcomes, facilitating neurophysiological research, educating and training surgeons, and reducing surgical complications and malpractice litigation. Informing patients about IONM is not only good practice and helpful in promoting the efficient use of IONM resources but is indispensable for effective shared decision making between the patient and surgeon. The International Neural Monitoring Study Group (INMSG) feels complete discussion of IONM in the preoperative planning and patient consent process is important in all patients undergoing thyroid and parathyroid surgery. The purpose of this publication is to evaluate the impact of IONM on the informed consent process before thyroid and parathyroid surgery and to review the current INMSG consensus on evidence-based consent. The objective of this consensus statement, which outlines general and specific considerations as well as recommended criteria for informed consent for the use of IONM, is to assist surgeons and patients in the processes of informed consent and shared decision making before thyroid and parathyroid surgery.
在过去的十年中，术中神经监测（IONM）在甲状腺和甲状旁腺手术中的应用已被外科医生广泛接受，被认为是一种有助于提高喉返神经识别和嗓音效果的有用技术，同时还能促进神经生理学研究、教育和培训外科医生，并降低手术并发症和医疗事故诉讼的风险。告知患者有关 IONM 的信息不仅是良好的实践，有助于促进 IONM 资源的有效利用，而且对于患者和外科医生之间有效的共同决策也是不可或缺的。国际神经监测研究组（INMSG）认为，在所有接受甲状腺和甲状旁腺手术的患者中，在术前计划和患者同意过程中对 IONM 进行完整的讨论非常重要。本出版物的目的是评估 IONM 对甲状腺和甲状旁腺手术前知情同意过程的影响，并回顾当前 INMSG 关于基于证据的同意的共识。本共识声明概述了一般和具体的考虑因素以及推荐的 IONM 使用知情同意标准，旨在协助外科医生和患者在甲状腺和甲状旁腺手术前的知情同意和共同决策过程中。
